Last checked at 25 Feb 2016 11:00
25 February 2016
Deltex Medical Group plc
("Deltex Medical" or "the Company")
Result of the General Meeting
Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring ("ODM"), is pleased to announce that at the General Meeting held earlier today, the resolution proposed was duly passed.
Application has been made for shares to be issued pursuant to the Placing and Open Offer announced on 3 February 2016 and on 23 February 2016. These will be admitted to trading at 8.00 a.m. tomorrow, 26 February 2016.
For further information, please contact:-
Deltex Medical Group plc | 01243 774 837 investorinfo@deltexmedical.com |
Nigel Keen, Chairman |
|
Ewan Phillips, Chief Executive |
|
Jonathan Shaw, Finance Director Barry Curtis, Company Secretary |
|
|
|
Nominated Adviser & Broker |
|
Arden Partners plc | 020 7614 5900 |
Chris Hardie |
|
Joint Broker Zeus Capital Limited Phil Walker Dominic Wilson |
020 3829 5000
|
Financial Public Relations |
|
IFC Advisory | 0203 053 8671 |
Tim Metcalfe Graham Herring Heather Armstrong |
|
|
|